Antifibrosis effects of total glucosides of Danggui-Buxue-Tang in a rat model of bleomycin-induced pulmonary fibrosis

Journal of Ethnopharmacology

Volumn 136, Issue 1, 2011, Pages 21-26

  Gao, Jian ^a,b   Huang, Yan ^a   Li, Ping ^b   Xu, Dujuan ^a   Li, Jun ^a   Liu, Yong ^a   Huang, Zhaogang ^a   Wu, Qiang ^a   Shao, Xu ^c  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c Hefei Seven Star Medicine and Technology Co Ltd   (China)

Author keywords

Pulmonary fibrosis; TGF 1; TNF ; Total glucosides of Danggui Buxue Tang; Type I collagen

Indexed keywords

ANGELICA ROOT EXTRACT; ASTRAGALOSIDE IV; ASTRAGALUS MEMBRANACEUS EXTRACT; BLEOMYCIN; COLLAGEN TYPE 1; CORTISONE; DANGGUI BUXUE TANG; EOSIN; GLUCOSIDE; HEMATOXYLIN; PLANT MEDICINAL PRODUCT; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTRAGALUS MEMBRANACEUS; BODY WEIGHT; CHINESE MEDICINE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; HERB; HISTOPATHOLOGY; LUNG FIBROSIS; LUNG HOMOGENATE; LUNG INJURY; LUNG PARENCHYMA; MALE; MEDICINAL PLANT; MICROSCOPY; NONHUMAN; PROTEIN EXPRESSION; RADIX ANGELICA; RAT; TREATMENT DURATION; WEIGHT REDUCTION;

ANIMALS; BLEOMYCIN; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; GLUCOSIDES; LUNG; MALE; PHYTOTHERAPY; PULMONARY FIBROSIS; RANDOM ALLOCATION; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

ANIMALIA; DANGGUI; RATTUS;

EID: 79958116138     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2011.03.013     Document Type: Article

References (28)

1. Brewer, G.J., Ullenbruch, M.R., Dick, R., Olivarez, L., Phan, S.H., 2003. Tetrathiomolyb-date therapy protects against bleomycin-induced pulmonary fibrosis in mice. Journal of Laboratory and Clinical Medicine 141, 210-216. (Pubitemid 36324239)
2. Chai, W.S., Li, Y.C., Wang, H.X., Guo, M., Li, Y.Q., 2003. The effects of angelica sinensis on pulmonary fibrosis in rats. Chinese Pharmacological Bulletin 19, 819-822. (Pubitemid 36992181)
3. Crouch, E., 1990. Pathobiology of pulmonary fibrosis. American Journal of Physiology 259, L159-L184. (Pubitemid 20342228)
4. El-Khatib, A.S., 2002. Possible modulatory role of nitric oxide in lung toxicity induced in rats by chronic administration of bleomycin. Chemotherapy 48, 244-251.
5. Elias, J.A., Zhu, Z., Chupp, G., Homer, R.J., 1999. Airway remodeling in asthma. Journal of Clinical Investigation 104, 1001-1006.
6. Gao, J., Li, J., Tong, C.L., Jin, Y., Lv, X.W., Guo, L., Xia, Y., 2006. Content determination of total glucosides of Yu Ping Feng and its preparation. China Journal of Chinese Materia Medica 31, 515-516.
7. Garantziotis, S., Steele, M.P., Schwartz, D.A., 2004. Pulmonary fibrosis: thinking outside of the lung. Journal of Clinical Investigation 114, 319-321. (Pubitemid 39071603)
8. Gao, J., Li, J., Ma, B.J., Cheng, W.M., Jin, Y., Lv, X.W., Yan, C., Wang, J.Q., Shao, X., Ge, S.X., 2007. Study on the extraction process for total glucosides of Yu Ping Feng with orthogonal design. Chinese Journal of Experimental Traditional Medical Formulae 13, 15-17.
9. Hahm, K.B., Im, Y.H., Lee, C., Parks, W.T., Bang, Y.J., Green, J.E., Kim, S.J., 2000. Loss of TGF-beta signaling contributes to autoimmune pancreatitis. Journal of Clinical Investigation 105, 1057-1065. (Pubitemid 30217690)
10. Huang, S.Q., Wang, B., Wang, J., Gao, L., Zhang, Y.B., Yan, C., 2005. Experiment on antiatherosis effect of daguibuxue decoction in rabbits. Beijing Zhong Yi Yao Da Xue Xue Bao 28, 140-144.
11. Huang, Y., Li, J., Wang, R., Wu, Q., Li, Y.H., Yu, S.C., Cheng, W.M., Wang, Y.Y., 2007. Effect of triterpene acids of Eriobotrya Japonica (Thunb.) Lindl. Leaf on inflammatory cytokines and mediums induction from alveolar macrophages of chronic bronchitis rats. Inflammation Research 56, 76-82.
12. Huang, Y., Li, J., Cao, Q., Yu, S.C., Lv, X.W., Jin, Y., Zhang, L., Zou, Y.H., Ge, J.F., 2006. Anti-oxidative effect of triterpene acids of Eriobotrya japonica (Thunb.) Lindl. leaf in chronic bronchitis rats. Life Science 78, 2749-2757.
13. Huang, Y., Li, J., Meng, X.M., Jiang, G.L., Li, H., Cao, Q., Yu, S.C., Lv, X.W., Cheng, W.M., 2009. Effect of triterpene acids of Eriobotrya japonica (Thunb.) Lindl. leaf and MAPK signal transduction pathway on inducible nitric oxide synthase expression in alveolar macrophage of chronic bronchitis rats. American Journal of Chinese Medicine 37, 1099-1111.
14. Kelly, M, Kolb, M., Bonniaud, P., Gauldie, J., 2003. aRe-evaluation of fibrogenic cytokines in lung fibrosis. Current Pharmaceutical Design 9, 39-49. (Pubitemid 36131704)
15. Kuroki, M., Noguchi, Y.J., Shimono, M., Tomono, K., Tashiro, T., Obata, Y.C., Nakayama, E., Kohno, S., 2003. Repression of bleomycin-induced pneumopathy by TNF. The Journal of Immunology 170, 567-574. (Pubitemid 36026184)
16. Leask, A., Andrew, L., David, J., 2004. TGF-(signaling and the fibrotic response. The FASEB Journal 18, 816-827.
17. Phan, S.H., Kunkel, S.L., 1992. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Experimental Lung Research 18, 29-43.
18. Shanahan, J.C., St Clair, W., 2002. Tumor necrosis factor-alpha blockade: a novel therapy for rheumatic disease. Clinical Immunology 103, 231-242.
19. Tak, P.P., Firestein, G.S., 2001. NF-kappaB: a key role in inflammatory diseases. Journal of Clinical Investigation 107, 7-11. (Pubitemid 32047405)
20. Thannickal, V.J., Flahert, K.R., M.rtinez, F.J, Lynch, J.P., 2004. Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapy. Expert Opinion on Pharmacotherapy 5, 1671-1686. (Pubitemid 39117710)
21. Tzurel, A., Segel, M.J., Reuven, O., Goldstein, R.H., Breuer, R., 2002. Halofuginone does not reduce fibrosis in bleomycin-induced lung injury. Life Science 71, 1599-1606. (Pubitemid 34874486)
22. Underwood, D.C., Osborn, R.R., Bochnowicz, S., Webb, E.F., Rieman, D.J., Lee, J.C., Romanic, A.M., Adams, J.L., Hay, D.W., Griswold, D.E., 2000. SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. American Journal of Physiology. Lung Cellular and Molecular Physiology 279, 895-902.
23. Wahl, S.M., Orenstein, J.M., Chen, W., 2000. TGF-beta influences the life and death decisions of T lymphocytes. Cytokine and Growth Factor Reviews 11, 71-79. (Pubitemid 30169727)
24. Wang, Q.J., Giri, S.N., Hyde, D.M., Li, C., 1991. Amelioration of bleomycininduced pulmonary fibrosis in hamsters by combined treatment with taurine and niacin. Biochemical Pharmacology 42, 1115-1122.
25. Wang, H.Y., Li, J.Z., Yu, L., Zhao, Y.N., Ding, W., 2004. Antifibrotic effect of the Chinese herbs Astragalus mongholicus and Angelica sinensis, in a rat model of chronic puromycin aminonucleoside nephrosis. Life Sciences 74, 1645-1658. (Pubitemid 38114793)
26. Yara, S., Kawakami, K., Kudeken, N., Tohyama, M., Teruya, K., Chinen, T., Awaya, A., Saito, A., 2001. FTS reduces bleomycin-induced cytokine and chemokine production and inhibits pulmonary fibrosis in mice. Clinical and Experimental Immunology 124, 77-85. (Pubitemid 32476937)
27. Zhang, H.M., Chen, S.W., Deng, X.F., Yang, X.G., Huang, X., 2006. Danggui-Buxue-Tang decoction has an anti-inflammatory effect in diabetic atherosclerosis rat model. Diabetes Research and Clinical Practice 74, 194-196. (Pubitemid 44764906)
28. Zhao, J.Q., Yi, Y.M., Xu, Y., 2007. Measurement of the total saponin in fistular onion bulb by vanillin chromatometry. Herald of Medicine 126, 1075-1076.